Track Aksharchem India share price today on NSE/BSE with real-time updates. Check stock performance, fundamentals, market cap, shareholding, financial reports, annual & quarterly results, and profit & ...

Other Operating Income------Total Income From Operations: 35.53: 46.53: 30.68: EXPENDITURE: Consumpt ...

The October-December quarter (Q3) of FY25 record deal-intake of $1.68 billion (up 29 per cent quarter-on-quarter or QoQ) could aid growth in Q4FY25 ...

UC Inclusive Credit Private Limited has sanctioned Term Loan of Rs. 8,00,00,000/- (Rupees Eight Crores Only) to Akme Fintrade (India) Limited. Shares of Akme Fintrade India Limited was last ...

Aug 13 (Reuters) - Kanchi Karpooram Ltd KCHI.BO : * JUNE QUARTER PROFIT 82.7 MILLION RUPEES VERSUS 100.4 MILLION RUPEES YEAR AGO * JUNE QUARTER INCOME FROM OPERATIONS 554.9 MILLION ...

Kanchi Karpooram Limited (KKL) a Public Limited Company was incorporated on January 31 1992. The Company manufactures Camphor its derivatives Gum Rosin Value Added Resins and Fortified Rosin. The ...

Stock Market Weekly Outlook: What Will Impact Sensex, Nifty From February 24-28? GDP Data Eyed Stock Market Dropped On February 21; Is Trump's New Tariff Threat The Reason Why Sensex, Nifty ...

Stock Market Crashed On February 17: Why Sensex Dropped 645 Pts & Nifty Fell 204 Pts On Monday? Stock Market Live Updates: Nifty 50 Hovers Around 22,800, Sensex Dips 300 Pts; Nifty Bank Down 0.50% ...

B-Right Realestate Limited ("Promoter 1") finalized Financial Closure, with Yogi Limited ("Investor"), for it's Mulund Project undertaken by it's Subsidiary M/s. Farewell Real Estates Private ...

Outcome of the Board meeting held on 29th May, 2024- Considered and approved the accounts and audited financial results (standalone and consolidated) for the FY 2023-24 Kanchi Karpooram Board Meeting ...

Renowned South Indian actress Pushpalatha passed away on February 5 in Chennai at the age of 87, following a prolonged illness. With a career spanning several decades, she acted in over 100 films ...

Emcure Pharmaceuticals received two observations from the USFDA after an inspection of its Pune-based API manufacturing facility. The company is addressing the observations and will respond to the ...